WuXi Biologics (Cayman) Inc. (WXXWY) Investment Research Dashboard
About WuXi Biologics (Cayman) Inc. (WXXWY) stock analysis
Get live WXXWY stock price $9.88, comprehensive WuXi Biologics (Cayman) Inc. stock analysis, charts, news, sentiment, sector analysis, and expert forecast. Real-time WXXWY stock data and investment insights.
Loading chart data...
WuXi Biologics (Cayman) Inc. (WXXWY) Overview
WuXi Biologics (Cayman) Inc. (WXXWY) is a publicly traded company in the Healthcare sector , specifically within the Biotechnology industry . As of the latest trading session, WXXWY trades at $9.88 with a market capitalization of 20.28B . Over the past 52 weeks, WXXWY has traded between $7.27 and $11.21 , with the current price positioned at approximately 66% of this range . The stock currently...
Key Takeaways
- Operates in the Healthcare sector (Biotechnology)
- Market cap: 20.28B
- Current price: $9.88
- 52-week range: $7.27 - $11.21
- P/E ratio: 7.60
Investment Score
A systematic tri-factor framework (valuation, quality, momentum) using trailing twelve-month fundamentals and current price momentum—aligned with the full investment score dashboard.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
WuXi Biologics (Cayman) Inc. delivers integrated solutions covering the entire lifecycle of biological drug development, from initial discovery to full-scale manufacturing. These services are provided to clients worldwide, with a significant presence...
Company Information
- CEO
- Zhisheng Chen
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 13252
Contact Information
- Address
- No. 108, Meiliang Road
- Country
- CN
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Valuation metrics suggest potential value opportunity (P/E: 7.6)
✓ Lower volatility stock (Beta: 0.58) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for WuXi Biologics (Cayman) Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for mid-cap stocks
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for WuXi Biologics (Cayman) Inc.
- ⚠Investors should consider how WuXi Biologics (Cayman) Inc. fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
20.28B
P/E Ratio (TTM)
7.60
Beta
0.58
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare WXXWY with peer companies:
- Price
- $3.73+5.67% (1D)
- Market cap
- 140.43M
- Price
- $1.44-8.28% (1D)
- Market cap
- 1.07M
- Price
- $1.56-3.70% (1D)
- Market cap
- 3.23M
- Price
- $94.19+3.37% (1D)
- Market cap
- 10.11B
- Price
- $2.34+0.00% (1D)
- Market cap
- 1.14B
- Price
- $2.31-1.70% (1D)
- Market cap
- 305.00M
- Price
- $0.51+0.00% (1D)
- Market cap
- 86.53M
- Price
- $123.96+0.00% (1D)
- Market cap
- 9.13B
- Price
- $0.01+0.00% (1D)
- Market cap
- 53.89K
- Price
- $295.81-6.33% (1D)
- Market cap
- 8.25B
- Price
- $58.01+0.00% (1D)
- Market cap
- 959.26M
- Price
- $1.04-2.08% (1D)
- Market cap
- 4.06M
- Price
- $0.00+0.00% (1D)
- Market cap
- 3.15K
- Price
- $0.00-10.00% (1D)
- Market cap
- 191.61K
- Price
- $183.86-2.24% (1D)
- Market cap
- 39.09B
- Price
- $199.92+0.00% (1D)
- Market cap
- 9.56B
- Price
- $19.63-4.34% (1D)
- Market cap
- 1.74B
- Price
- $0.22+0.00% (1D)
- Market cap
- 232.26K
- Price
- $0.00-75.00% (1D)
- Market cap
- 124
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.
Healthcare (1D)
78/100 ⭐⭐⭐⭐⭐
- Overall
- +0.7%
- NYSE
- +0.6%
- NASDAQ
- +0.7%
| Sector | 1D | 1W | 1M | P/E | Score |
|---|---|---|---|---|---|
| Financial Services | +2.2% | +3.1% | +4.3% | 19.3 | 98/100⭐⭐⭐⭐⭐ |
| Healthcare | +0.7% | +1.3% | +1.6% | 24.1 | 78/100⭐⭐⭐⭐⭐ |
| Communication Services | +1.4% | -0.7% | +2.9% | 22.2 | 74/100⭐⭐⭐⭐⭐ |
| Consumer Defensive | -0.2% | +1.8% | +0.7% | 29.7 | 64/100⭐⭐⭐⭐ |
| Basic Materials | +0.4% | +1.2% | -0.2% | 25.2 | 61/100⭐⭐⭐⭐ |
| Real Estate | -0.5% | +0.0% | -2.5% | 29.2 | 43/100⭐⭐⭐ |
| Energy | -2.1% | -3.7% | -4.1% | 19.1 | 39/100⭐⭐ |
| Utilities | -1.0% | +0.0% | -4.4% | 26.8 | 37/100⭐⭐ |
| Industrials | +0.6% | +0.4% | -9.9% | 30.1 | 23/100⭐ |
| Consumer Cyclical | +0.5% | -1.5% | -5.8% | 43.0 | 18/100⭐ |
| Technology | +0.6% | -1.6% | -7.2% | 40.7 | 15/100⭐ |
Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-07-29.